SID/Madrid welcomes Reiwa Healthcare to its community in Tres Cantos. The company, a European pharmaceutical firm based in Madrid focused on the development, management, and marketing of generic medicines, is joining the campus to advance its growth in a collaborative and innovative environment.
Reiwa Healthcare currently has medicines registered in Spain, Germany, Portugal and Hungary, and conducts its business with an international vocation that fits with SID/Madrid's ecosystem approach.
“We chose SID/Madrid because it represents the environment that best supports our vision: a specialised community focused on health, with talent, strategic connections and an ecosystem that drives innovation. Establishing our headquarters here allows us to grow surrounded by companies that share our ambition and purpose,” says Jorge Santos, CEO of Reiwa Healthcare.
In this new stage on campus, the Reiwa Healthcare team will work to consolidate its structure and expand its product portfolio, with the aim of strengthening its position in the Spanish domestic market and advancing its international expansion.
“The incorporation of Reiwa Healthcare reinforces the presence of the healthcare sector in SID/Madrid and adds a company with a vocation for growth and international projection to our community,” says Pilar Gil, co-CEO of SID.
With this incorporation, SID/Madrid continues to consolidate an ecosystem designed to support health companies at key stages, fostering connections with other stakeholders and access to an environment intended to accelerate projects with real impact.
